Impact of Insulin Sensitivity in Relationship with Prolactin and Thyroid Stimulating Hormone

Abstract

Introduction: It is well recognized that there is a close relationship between TSH and PRL levels. The aim of this study was to evaluate the impact of insulin sensitivity on the association between TSH and PRL in euthyroid obese subjects.

Material and Methods: Retrospective cross-sectional analysis was carried out on 165 euthyroid obese or overweight female patients. Prolactin, TSH, free thyroxine (FT4), free triiodothyronine (FT3), fasting plasma levels of insulin and glucose, postprandial levels of glucose, homeostasis model assessment (HOMA) for insulin resistance (HOMA-IR) and insulin secretion (HOMA-β cell), body weight, height, body mass index (BMI) and waist circumference were assessed. Statistical tests used were unpaired Student's t-test adjusted by Bonferroni's method and Pearson correlations with Bonferroni corrections.

Results: There was no significant difference in prolactin levels between insulin sensitive and resistant subjects. Compared to insulin sensitive subjects, TSH levels were higher in insulin resistant subjects but it was not statistically significant. We observed significant positive correlation between prolactin and TSH in insulin sensitive and normoglycemic subjects (r=0.273, p=0.039 and r=0.253, p=0.023, respectively) but this correlation was lost in insulin resistant subjects and subjects who had fasting glucose levels ≥100 mg/dl (r=0.057, p=0.609 and r=0.090, p=0.404, respectively).

Conclusions: The findings of this study provide some clues about the relationship between PRL and TSH in insulin sensitive obese subjects. The insulin sensitivity and carbohydrate homeostasis seem to be involved in relationship with PRL and TSH by the brain via serotoninergic and dopaminergic system.

insulin sensitivity - TSH - prolactin

References

• 1 Stokholm KH, Lindgreen P. Serum free triiodothyronine in obesity.  Int J Obes. 1982;  6 573-578
• 2 Glass AR, Burman KD, Dahms WT, Boehm TM. Endocrine function in human obesity.  Metabolism. 1981;  30 89-104
• 3 Roti E, Minelli R, Salvi M. Thyroid hormone metabolism in obesity.  Int J Obes Relat Metab Disord. 2000;  24 (Suppl 2) 113-115
• 4 Strata A, Ugolotti G, Contini C, Magnati G, Pugnoli C, Tirelli F, Zuliani U. Thyroid and obesity: survey of some function tests in a large obese population.  Int J Obes. 1978;  2 333-340
• 5 Duntas L, Hauner H, Rosenthal J, Pfeiffer EF. Thyrotropin releasing hormone (TRH) immunoreactivity and thyroid function in obesity.  Int J Obes Relat Metab Disord. 1991;  15 83-87
• 6 Naslund E, Andersson M, Degerblad P, Kogner P, Kral JG, Rössner S. et al . Associations of leptin, insulin resistance and thyroid function with long-term weight loss in dieting obese men.  J Intern Med. 2000;  248 299-308
• 7 Tagliaferri M, Berselli ME, Calo G, Minocci A, Savia G, Petroni ML. et al . Subclinical hypothyroidism in obese patients: relation to resting energy expenditure, serum leptin, body composition, and lipid profile.  Obes Res. 2001;  9 196-201
• 8 Rosenbaum M, Hirsch J, Murphy E, Leibel RL. Effects of changes in body weight on carbohydrate metabolism, catecholamine excretion, and thyroid function.  Am J Clin Nutr. 2000;  71 1421-1432
• 9 Ritz P, Dumas JF, Salle A, Simard G, Malthiery Y, Rohmer V. Thyroid hormones and obesity.  Ann Endocrinol. 2002;  63 135-139
• 10 Krotkiewski M. Thyroid hormones and treatment of obesity.  Int J Obes Relat Metab Disord. 2000;  24 ((Suppl.2)) 116-119
• 11 Kopelman PG, White N, Pilkington TR, Jeffcoate SL. Impaired hypothalamic control of prolactin secretion in massive obesity.  Lancet. 1979;  1 747-750
• 12 Kopelman PG, Pilkington TR, Wite N, Jeffcoate SL. Persistence of abnormal hypothalamic control of prolactin secretion in some obese women after weight reduction.  Br Med J. 1980;  281 358-359
• 13 AvRuskin TW, Pillai S, Kasi K. et al . Decreased prolactin secretion in childhood obesity.  J Paediat. 1985;  106 373-378
• 14 Jung RT, Campbell RG, James WPT, Callingham BA. Altered hypothalamic sympathetic responses to hypoglycaemia in familial obesity.  Lancet. 1982;  1 1043-1046
• 15 Donders SHJ, Pieters GF, Heeval JG. et al . Disparity of thyrotrophin (TSH) and prolactin responses to TSH-releasing hormone in obesity.  J Clin Endocr Metab. 1985;  61 56-59
• 16 Snyder PJ, Jacobs LS, Utiger RD, Daughaday WH. Thyroid hormone inhibition of the prolactin response to thyrotropin-releasing hormone.  J Clin Invest. 1973;  52 2324-2329
• 17 Weaver JU, Noonan K, Kopelman PG. An association between hypothalamic-pituitary dysfunction and peripheral endocrine function in extreme obesity.  Clin Endocrinol. 1991;  35 97-102
• 18 Ortega-Gonzalez C, Cardoza L, Coutino B, Hidalgo R, Arteaga-Troncoso G, Para A. Insulin sensitizing drugs increase the endogenous dopaminergic tone in obese insulin-resistant women with polycystic ovary syndrome.  J Endocrinol. 2005;  184 233-239
• 19 Matthews DR, Hosker JP, Rudenski AS, Naylor BA, DF, Turner RC. Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man.  Diabetologia. 1985;  28 412-419
• 20 Lebovitz HE. Insulin resistance and the insulin resistance syndrome. In : Clinician's manual on insulin resistance. London, Science Pres 2002 pp. 1-15
• 21 The Expert Committee on the Diagnosis and Classification of Diabetes Mellitus . Follow-up Report on the Diagnosis of Diabetes Mellitus.  Diabetes Care. 2003;  26 3160-3167
• 22 Copinschi G, Dehaet MH, Brian JP. et al . Simultaneous study of cortisol, growth hormone and prolactin nyctohemeral variations in normal and obese subjects. Influence of prolonged fasting in obesity.  Clin Endocrinol. 1978;  9 15-26
• 23 Kopelman PG. Physiopathology of prolactin secretion in obesity.  Int J Obes Relat Metab Disord. 2000;  24 (Suppl 2) S104-108
• 24 Padayatti PS, Paulose CS. 2-Adrenergic and high affinity serotonergic receptor changes in the brain stem of streptozotocin-induced diabetic rats.  Life Sci. 1999;  65 403-414
• 25 Jackson J, Paulose CS. Enhancement of [m-methoxy 3 H]MDL100907 binding to 5HT2A receptors in cerebral cortex and brain stem of streptozotocin induced diabetic rats.  Mol Cell Biochem. 1999;  199 81-85
• 26 Horacek J, Kuzmiakova M, Hoschl C, Andel M, Bahbonh R. The relationship between central serotonergic activity and insulin sensitivity in healthy volunteers.  Psychoneuroendocrinology. 1999;  24 785-797
• 27 Yuan X, Yamada K, Ishiyama-Shigemoto S, Koyama W, Nonaka K. Identification of polymorphic loci in the promoter region of the serotonin 5-HT2C receptor gene and their association with obesity and type II diabetes.  Diabetologia. 2000;  43 373-376
• 28 Rosmond R, Bouchard C, Bjorntorp P. Increased abdominal obesity in subjects with a mutation in the 5-HT(2A) receptor gene promoter.  Ann NY Acad Sci. 2002;  967 571-575
• 29 Rojdmark S, Rossner S. Decreased dopaminergic control of prolactin secretion in male obesity: normalization by fasting.  Metabolism. 1991;  40 191-195
• 30 Bernini GP, Argenio GF, Vivaldi MS, Del Corso C, Sgro M, Franchi F, Luisi M. Effects of fenfluramine and ritanserin on prolactin response to insulin-induced hypoglycemia in obese patients: evidence for failure of the serotoninergic system.  Horm Res. 1989;  31 133-137
• 31 Altomonte L, Zoli A, Alessi F, Ghirlanda G, Manna R, Greco AV. Effect of fenfluramine on growth hormone and prolactin secretion in obese subjects.  Horm Res. 1987;  27 190-194
• 32 Zimmermann-Belsing T, Brabant G, Holst JJ, Feldt-Rasmussen U. Circulating leptin and thyroid dysfunction.  Eur J Endocrinol. 2003;  149 257-271
• 33 Menendez C, Baldelli R, Camina JP. et al . TSH stimulates leptin secretion by a direct effect on adipocytes.  J Endocrinol. 2003;  176 7-12
• 34 Seoane LM, Carro E, Tovar S, Casanueva FF, Dieguez C. Regulation of in vivo TSH secretion by leptin.  Regul Pept. 2000;  25 25-29

Correspondence